Proto Script Pharmaceutical Stock Performance
| PSCR Stock | USD 0.0001 0.00 0.00% |
Proto Script holds a performance score of 6 on a scale of zero to a hundred. The company holds a Beta of 2.03, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Proto Script will likely underperform. Use Proto Script treynor ratio and day median price , to analyze future returns on Proto Script.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Proto Script Pharmaceutical are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating fundamental indicators, Proto Script reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Proto |
Proto Script Relative Risk vs. Return Landscape
If you would invest 0.01 in Proto Script Pharmaceutical on September 26, 2025 and sell it today you would earn a total of 0.00 from holding Proto Script Pharmaceutical or generate 0.0% return on investment over 90 days. Proto Script Pharmaceutical is currently generating 1.3021% in daily expected returns and assumes 16.3474% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Proto, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Proto Script Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Proto Script's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Proto Script Pharmaceutical, and traders can use it to determine the average amount a Proto Script's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0797
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | PSCR | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Proto Script is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Proto Script by adding it to a well-diversified portfolio.
Proto Script Fundamentals Growth
Proto Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Proto Script, and Proto Script fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Proto Pink Sheet performance.
| Return On Asset | -2.41 | |||
| Operating Margin | (1.60) % | |||
| Current Valuation | 464.66 K | |||
| Shares Outstanding | 49.14 M | |||
| Price To Earning | 17.07 X | |||
| Price To Sales | 0.15 X | |||
| Revenue | 788.96 K | |||
| EBITDA | (962.57 K) | |||
| Cash And Equivalents | 56.36 K | |||
| Total Debt | 372.75 K | |||
| Debt To Equity | 0.62 % | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | 44.1 K | |||
| Earnings Per Share | (0.06) X | |||
| Total Asset | 170.19 K | |||
| Retained Earnings | (186 K) | |||
| Current Asset | 12 K | |||
| Current Liabilities | 89 K | |||
About Proto Script Performance
Assessing Proto Script's fundamental ratios provides investors with valuable insights into Proto Script's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Proto Script is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California. Proto Script operates under Specialty Business Services classification in the United States and is traded on OTC Exchange.Things to note about Proto Script Pharmac performance evaluation
Checking the ongoing alerts about Proto Script for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Proto Script Pharmac help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Proto Script Pharmac is way too risky over 90 days horizon | |
| Proto Script Pharmac has some characteristics of a very speculative penny stock | |
| Proto Script Pharmac appears to be risky and price may revert if volatility continues | |
| Proto Script Pharmac has high likelihood to experience some financial distress in the next 2 years | |
| Proto Script Pharmaceutical currently holds 372.75 K in liabilities with Debt to Equity (D/E) ratio of 0.62, which is about average as compared to similar companies. Proto Script Pharmac has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Proto Script until it has trouble settling it off, either with new capital or with free cash flow. So, Proto Script's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Proto Script Pharmac sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Proto to invest in growth at high rates of return. When we think about Proto Script's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 788.96 K. Net Loss for the year was (7.18 M) with profit before overhead, payroll, taxes, and interest of 564.47 K. |
- Analyzing Proto Script's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Proto Script's stock is overvalued or undervalued compared to its peers.
- Examining Proto Script's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Proto Script's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Proto Script's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Proto Script's pink sheet. These opinions can provide insight into Proto Script's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Proto Pink Sheet Analysis
When running Proto Script's price analysis, check to measure Proto Script's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Proto Script is operating at the current time. Most of Proto Script's value examination focuses on studying past and present price action to predict the probability of Proto Script's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Proto Script's price. Additionally, you may evaluate how the addition of Proto Script to your portfolios can decrease your overall portfolio volatility.